Skip to main content
. 2013 May 1;18(5):600–610. doi: 10.1634/theoncologist.2012-0480

Table 5.

Survival analysis associated with treatment with docetaxel, pemetrexed, and bevacizumab in advanced non-small cell lung cancer

graphic file with name onc00513-1331-t05.jpg

aHR was calculated by the multivariable Cox regression model with each variable of interest after adjusting for age, sex, race, stage, histology, and Medicare status.

bHR was calculated by the multivariable Cox regression model with each variable of interest after adjusting for age, sex, race, histology, and Medicare status.

cHR was calculated by the multivariable Cox regression model with each variable of interest after adjusting for age, sex, race, stage, and Medicare status.

dHR was calculated by the multivariable Cox regression model with each variable of interest after adjusting for age, sex, race, and Medicare status.

Abbreviations: CI, confidence interval; HR, hazard ratio; NA, not available; NSCLC, non-small cell lung cancer; OS, overall survival; Ref, reference.